Lower Levels of High-density Lipoprotein Cholesterol on Admission and A Recurrence of Ischemic Stroke: A 12-month Follow-up of the Fukuoka Stroke Registry

被引:11
作者
Kuwashiro, Takahiro [1 ]
Sugimori, Hiroshi [1 ]
Kamouchi, Masahiro [1 ]
Ago, Tetsuro [1 ]
Kitazono, Takanari [1 ]
Iida, Mitsuo [1 ]
机构
[1] Kyushu Univ, Dept Med & Clin Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan
关键词
Angiotensin receptor blocker; high density lipoprotein; ischemic stroke; recurrence; NORTHERN MANHATTAN STROKE; CORONARY-HEART-DISEASE; LONG-TERM RISK; ATRIAL-FIBRILLATION; INTERVENTION TRIAL; OXIDIZED PHOSPHOLIPIDS; SECONDARY PREVENTION; CEREBRAL INFARCTION; JAPANESE PATIENTS; COMMUNITY STROKE;
D O I
10.1016/j.jstrokecerebrovasdis.2010.12.011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Despite recent progress in treatments for secondary prevention, ischemic stroke recurs in 8% to 12% of stroke survivors. We investigated the predisposing factors associated with recurrence within the first 12 months after an ischemic event to explore more effective preventive strategies. Methods: Between June 2007 and April 2008, acute (within 7 days of onset) ischemic stroke patients were registered in the Fukuoka Stroke Registry (FSR), a multicenter, prospective, observational database. The clinical characteristics on admission were analyzed, and the patients were followed for 12 months. Results: Two hundred sixty patients (151 males and 109 females, 71 +/- 11 years of age) were registered; 25 (9.6%) had recurrence of ischemic stroke during the follow-up period. Kaplan-Meier curve analysis revealed a significant difference in recurrence-free survival between patients with high-density lipoprotein (HDL) cholesterol <40 mg/dL on admission and those with HDL cholesterol >= 40 mg/dL (P = .042). Adjusted multivariate logistic regression analysis showed that age (odds ratio 1.06; 95% CI, 1.00-1.11; P = .035) and HDL cholesterol,40 mg/dL (odds ratio 2.73; 95% CI, 1.01-7.38; P = .048) on admission were independently associated with a recurrence of ischemic stroke within 12 months of the initial onset. Conclusions: Aging and low HDL cholesterol levels are considered independent risk factors for a recurrence of ischemic stroke.
引用
收藏
页码:561 / 568
页数:8
相关论文
共 46 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial [J].
Amarenco, Pierre ;
Goldstein, Larry B. ;
Callahan, Alfred, III ;
Sillesen, Henrik ;
Hennerici, Michael G. ;
O'Neill, Blair J. ;
Rudolph, Amy E. ;
Simunovic, Lisa ;
Zivin, Justin A. ;
Welch, K. M. A. .
ATHEROSCLEROSIS, 2009, 204 (02) :515-520
[3]  
Amarenco P, 2006, NEW ENGL J MED, V355, P549
[4]   Poor outcome after first-ever stroke - Predictors for death, dependency, and recurrent stroke within the first year [J].
Appelros, P ;
Nydevik, I ;
Viitanen, M .
STROKE, 2003, 34 (01) :122-126
[5]   A role for oxidized phospholipids in artherosclerosis [J].
Berliner, JA ;
Watson, AD .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (01) :9-11
[6]   Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis [J].
Briel, Matthias ;
Ferreira-Gonzalez, Ignacio ;
You, John J. ;
Karanicolas, Paul J. ;
Akl, Elie A. ;
Wu, Ping ;
Blechacz, Boris ;
Bassler, Dirk ;
Wei, Xinge ;
Sharman, Asheer ;
Whitt, Irene ;
da Silva, Suzana Alves ;
Khalid, Zahira ;
Nordmann, Alain J. ;
Zhou, Qi ;
Walter, Stephen D. ;
Vale, Noah ;
Bhatnagar, Neera ;
O'Regan, Christopher ;
Mills, Edward J. ;
Bucher, Heiner C. ;
Montori, Victor M. ;
Guyatt, Gordon H. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338
[7]   LONG-TERM RISK OF RECURRENT STROKE AFTER A FIRST-EVER STROKE - THE OXFORDSHIRE COMMUNITY STROKE PROJECT [J].
BURN, J ;
DENNIS, M ;
BAMFORD, J ;
SANDERCOCK, P ;
WADE, D ;
WARLOW, C .
STROKE, 1994, 25 (02) :333-337
[8]   High density lipoprotein cholesterol and the risk of stroke in elderly men [J].
Curb, JD ;
Abbott, RD ;
Rodriguez, BL ;
Masaki, KH ;
Chen, R ;
Popper, JS ;
Petrovitch, H ;
Ross, GW ;
Schatz, IJ ;
Belleau, GC ;
Yano, K .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (02) :150-157
[9]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[10]   Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program [J].
Ducharme, Anique ;
Swedberg, Karl ;
Pfeffer, Marc A. ;
Cohen-Solal, Alain ;
Granger, Christopher B. ;
Maggioni, Aldo P. ;
Michelson, Eric L. ;
McMurray, John J. V. ;
Olsson, Lars ;
Rouleau, Jean L. ;
Young, James B. ;
Olofsson, Bertil ;
Puu, Margareta ;
Yusuf, Salim .
AMERICAN HEART JOURNAL, 2006, 152 (01) :86-92